The tumor suppressor Liver Kinase B1 (LKB1) is an important regulator of pancreatic β cell biology. LKB1-dependent phosphorylation of distinct AMPK family members determines proper β cell polarity and restricts β cell size, total β cell mass and glucose-stimulated insulin secretion (GSIS). However the full spectrum of LKB1 effects and the mechanisms involved in the secretory phenotype remains incompletely understood. We report here that in the absence of LKB1 in β cells, GSIS is dramatically and persistently improved. The enhancement is seen both in vivo and in vitro, and cannot be explained by altered cell polarity, increased β cell number or increased insulin content. Increased secretion does require membrane depolarization and calcium influx, but appears to rely mostly on a distal step in the secretion pathway. Surprisingly, enhanced GSIS is seen despite profound defects in mitochondrial structure and function in LKB1-deficient β cells, expected to greatly diminish insulin secretion via the classic triggering pathway. Thus LKB1 is essential for mitochondrial homeostasis in β cells, and in parallel is a powerful negative regulator of insulin secretion. This study shows that β cells can be manipulated to enhance GSIS to supra-normal levels even in the face of defective mitochondria, and without deterioration over months.